Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Mirum Pharmaceuticals Inc (MIRM)

325 + Investors. Track Smart Money conviction in MIRM. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +31
Streak
7Q ▲
Buyers last Q
60%

Smart Money Signals — MIRM

Based on 309 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 7 quarters in a row

last 6Q
For 7 consecutive quarters, more hedge funds added MIRM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
309 hedge funds hold MIRM right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +45% more funds vs a year ago

fund count last 6Q
+96 new funds entered over the past year (+45% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 60% buying

186 buying125 selling
Last quarter: 186 funds were net buyers (68 opened a brand new position + 118 added to an existing one). Only 125 were sellers (88 trimmed + 37 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+7 vs last Q)

new funds entering per quarter
Funds opening a new MIRM position: 34 → 70 → 61 → 68. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

41% of holders stayed for 2+ years

■ 41% conviction (2yr+) ■ 24% medium ■ 35% new
127 out of 309 hedge funds have held MIRM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +28% but shares only +12% — price-driven

Value
+27%
Shares
+11%
Last quarter: the total dollar value of institutional holdings rose +28%, but actual share count only changed +12%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

37 → 34 → 70 → 61 → 68 new funds/Q
New funds entering each quarter: 34 → 70 → 61 → 68. A growing number of institutions are discovering MIRM each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 46% veterans vs 41% newcomers

■ 46% veterans ■ 13% 1-2yr ■ 41% new
Entry-cohort mix of 314 holders: 144 (46%) are 2+ year veterans, 40 entered 1–2 years ago, and 130 (41%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 44% AUM from top-100 funds

44% from top-100 AUM funds
55 of 307 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in MIRM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — MIRM

In 2026 Q1, 186 hedge funds were net buyers of MIRM (68 opened a new position, 118 added to an existing one), while 125 reduced or exited (88 trimmed, 37 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. This marks 7 consecutive quarters of net institutional buying — a persistent conviction signal. 44% of total institutional value in MIRM is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +31 funds (more new holders than closures). Total institutional holders: 309.

Hedge Fund Ownership: MIRM

How many hedge funds hold MIRM — quarterly history vs. share price
Quarterly hedge fund ownership of MIRM vs. share price

Market Analysis: MIRM

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: MIRM

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Growing Institutional Interest

Quality funds are building positions — conviction is rising but not yet widespread.

21 top-rated funds 11 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
6.9
/ 10
conviction
Hedge Fund Positioning: MIRM
325 + Investors

Track Smart Money conviction in MIRM. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 325 309 5.18%
13F Shares 71M 68M 4.3%
Total Value $7.88B $6.02B 30.97%
New Positions 67 68 -1
Increased Positions 124 118 +6
Closed Positions 48 37 +11
Reduced Positions 100 84 +16
Total Calls 4 4 -
Total Puts 4 3 33.33%
PUT/CALL Ratio 1.0 0.75 Neutral

Statistics: MIRM

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

325 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in MIRM. Verified SEC 13F-HR filings.

QUARTER:
Top 25 MIRM holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Frazier Life Sciences Management, L.P. 19.58% 7,679,684 $899.1M
2 Boone Capital Management LLC 11.38% 415,641 $48.7M
3 Novo Holdings A/S 7.65% 1,125,000 $131.7M
4 Tang Capital Management LLC 6.57% 1,236,027 $144.7M
5 Highlander Partners, L.P. 4.83% 122,980 $14.4M
6 Patient Square Capital LP 4.72% 260,500 $30.5M
7 Rock Springs Capital Management LP 4.56% 798,145 $93.4M
8 Trails Edge Capital Partners, LP 4.15% 223,312 $26.1M
9 Octagon Capital Advisors LP 3.57% 338,900 $39.7M
10 Atle Fund Management AB 3.17% 100,807 $11.8M
11 Bvf Inc/Il 3.16% 1,056,027 $123.6M
12 TCG Crossover Management, LLC 2.99% 1,062,049 $124.3M
13 First Turn Management, LLC 2.73% 218,051 $25.5M
14 NAN FUNG TRINITY (HK) Ltd 2.69% 232,679 $27.2M
15 Next Century Growth Investors LLC 2.61% 420,213 $49.2M
16 Penn Capital Management Company, LLC 2.22% 298,914 $35.1M
17 Seven Fleet Capital Management LP 2.13% 110,393 $12.9M
18 Eventide Asset Management, LLC 1.95% 1,248,389 $146.2M
19 Lisanti Capital Growth, LLC 1.63% 63,295 $7.4M
20 Essex Investment Management Co LLC 1.62% 105,669 $12.4M
21 Rhenman & Partners Asset Management AB 1.54% 139,205 $16.3M
22 Resolute Capital Asset Partners LLC 1.50% 30,000 $3.5M
23 Emerald Advisers, LLC 1.29% 468,295 $54.8M
24 Emerald Mutual Fund Advisers Trust 1.19% 289,372 $33.9M
25 Nicholas Investment Partners, LP 1.14% 172,695 $20.2M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Mirum Pharmaceuticals Inc (MIRM)

What does the Smart Money Trend signal show for MIRM?

Buying streak — 7 quarters in a row: For 7 consecutive quarters, more hedge funds added MIRM than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for MIRM?

More buyers than sellers — 60% buying: Last quarter: 186 funds were net buyers (68 opened a brand new position + 118 added to an existing one). Only 125 were sellers (88 trimmed + 37 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for MIRM holders?

Elite ownership — 44% AUM from top-100 funds: 55 of 307 holders are among the 100 largest funds by AUM, controlling 44% of total institutional value in MIRM. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held MIRM?

41% of holders stayed for 2+ years: 127 out of 309 hedge funds have held MIRM for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →